Inventor · disambiguated record
Douglas Giles Johnson
Also filed as: JOHNSON DOUGLAS G · JOHNSON DOUGLAS GILES
11 granted patents·5 pending applications·110 citations·filing 1991–2021
89Inventor score
Files withRTU PHARMACEUTICALS LLC4ALLOS THERAPEUTICS INC3BAXTER INT3CLINTEC NUTRITION CO1NACUITY PHARMACEUTICALS INC1
Top patents by PatentIndex Score
16 records- 0192US11548851B2Method for preparation of n-acetyl cysteine amide and derivatives thereofNACUITY PHARMACEUTICALS INC·Filed 2021·Granted Jan 10, 2023·3 cites·17 claims
- 0282US5539100AOrganic solid state switches incorporating porphyrin compounds and method for producing organic solid state optical switchesUS ARMY·Filed 1993·Granted Jul 23, 1996·70 cites·9 claims
- 0372US10278959B2Ready to use ketorolac formulationsRTU PHARMACEUTICALS LLC·Filed 2018·Granted May 7, 2019·1 cites·20 claims
- 0469US9962371B2Ready to use ketorolac formulationsRTU PHARMACEUTICALS LLC·Filed 2016·Granted May 8, 2018·1 cites·21 claims
- 0569US2022023260A1Ready to Use Ketorolac FormulationsRTU PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 0668US11116750B2Ready to use ketorolac formulationsRTU PHARMACEUTICALS LLC·Filed 2018·Granted Sep 14, 2021·0 cites·21 claims
- 0765US9421191B2Ready to use ketorolac formulationsPERGOLIZZI JOSEPH V·Filed 2011·Granted Aug 23, 2016·1 cites·19 claims
- 0855US5650421APremixed famotidine formulationBAXTER INT·Filed 1995·Granted Jul 22, 1997·18 cites·8 claims
- 0954US2007212302A1Preparation and Use of a Stable Formulation of Allosteric Effector CompoundsALLOS THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 1046US2003232887A1Preparation and use of a stable formulation of allosteric effector compoundsFiled 2002·Application pending·0 cites
- 1143US7847120B2Compositions of allosteric hemoglobin modifiers and methods of making the sameUNIV VIRGINIA COMMONWEALTH·Filed 2005·Granted Dec 7, 2010·0 cites·40 claims
- 1241US5206269AHighly concentrated amino acid solutionCLINTEC NUTRITION CO·Filed 1992·Granted Apr 27, 1993·8 cites·15 claims
- 1341US2008039425A1Methods and Compositions to Reduce Tissue Irritation in Parenteral FormulationsALLOS THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 1441US2007299136A1Crystalline and Amorphous Forms of Efaproxiral SodiumALLOS THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 1534US5304571AUnbuffered premixed ranitidine formulationBAXTER INT·Filed 1992·Granted Apr 19, 1994·4 cites·4 claims
- 1634US5169864AUnbuffered premixed ranitidine formulationBAXTER INT·Filed 1991·Granted Dec 8, 1992·4 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Douglas Giles Johnson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →